
|Videos|February 9, 2022
INSPIRE and IMvigor011 Trials
Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.
Advertisement
Episodes in this series
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
2
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
3
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
4
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
5

















































